Fragment of cytokeratin 19 in the blood
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
The reference values (norm) of the concentration of the fragment of cytokeratin 19 (CYFRA-21-1) in serum - up to 3.3 ng / ml.
Cytokeratins are insoluble skeletal proteins. Unlike cytokeratins, fragments of cytokeratin are soluble in serum. Cytokeratins play an important role in tissue differentiation. CYFRA-21-1 has good specificity for benign lung diseases, the 3.3 ng / ml separation point provides a specificity of 95%. A slight rise in CYFRA-21-1 to 10 ng / ml is detected with progressive benign liver diseases and especially with kidney failure.
CYFRA-21-1 is a marker of non-small cell carcinoma of the lung. With a specificity of 95%, CYFRA-21-1 has a significantly higher sensitivity (49%) than CEA (29%). The sensitivity of CYFRA-21-1 in squamous cell carcinoma of the lungs is much higher (60%) than the sensitivity of CEA (18%). CYFRA-21-1 and CEA show a similar diagnostic sensitivity (42% and 40%, respectively) for pulmonary adenocarcinoma. The combination of these two markers increases the sensitivity to 55%.
CYFRA-21-1 is the most informative of all known markers for monitoring muscular-invasive bladder carcinoma. With a specificity of 95%, CYFRA-21-1 has a sensitivity of 56% for invasive tumors of all stages. The sensitivity of CYFRA-21-1 depends on the stage of the disease: 4% at stage I, more than 33% at stage II, 36% at III, and 73% at stage IV of bladder cancer.
More than 50% of bladder tumors do not infiltrate the muscle layer. They are easily detected by urological examination. It is more difficult to diagnose invasive tumors. Monitoring of CYFRA-21-1 markers in many cases allows revealing such forms of bladder carcinoma.